Andrew Spaventa's Insider Trades & SAST Disclosures
Andrew Spaventa's most recent trade in Singular Genomics Systems Inc was a trade of 1,907 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Andrew Spaventa.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 1,907 | 22,873 | - | - | Restricted Stock Units | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 1,907 | 2,232 | - | - | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Feb 2025 | 1,107 | 142,900 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Feb 2025 | 1,107 | 325 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.89 per share. | 12 Feb 2025 | 800 | 1,432 | - | 19.9 | 15,912 | Common Stock |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 486 | 811 | - | - | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 486 | 4,374 | - | - | Restricted Stock Units | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2024 | 306 | 141,793 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2024 | 306 | 325 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.16 per share. | 15 Dec 2024 | 180 | 631 | - | 20.2 | 3,629 | Common Stock |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2024 | 1,907 | 2,232 | - | - | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2024 | 1,907 | 24,780 | - | - | Restricted Stock Units | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2024 | 1,212 | 325 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2024 | 1,212 | 141,487 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 22.55 per share. | 12 Nov 2024 | 695 | 1,537 | - | 22.5 | 15,669 | Common Stock |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 487 | 812 | - | - | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 487 | 4,860 | - | - | Restricted Stock Units | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Sep 2024 | 312 | 140,275 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Sep 2024 | 312 | 325 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.38 per share. | 15 Sep 2024 | 175 | 637 | - | 12.4 | 2,167 | Common Stock |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 1,906 | 2,231 | - | - | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 1,906 | 26,687 | - | - | Restricted Stock Units | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Aug 2024 | 1,225 | 139,963 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Aug 2024 | 1,225 | 325 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.12 per share. | 12 Aug 2024 | 681 | 1,550 | - | 7.1 | 4,849 | Common Stock |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Jun 2024 | 14,584 | 4,162,144 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 14,584 | 160,416 | - | - | Restricted Stock Units | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Jun 2024 | 14,584 | 9,766 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 14,584 | 24,350 | - | - | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2024 | 57,188 | 857,812 | - | - | Restricted Stock Units | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2024 | 57,188 | 66,954 | - | - | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 May 2024 | 57,188 | 9,766 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 May 2024 | 57,188 | 4,147,560 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 14,583 | 24,349 | - | - | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Mar 2024 | 14,583 | 4,090,372 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Mar 2024 | 14,583 | 9,766 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 14,583 | 175,000 | - | - | Restricted Stock Units | |
| Singular Genomics Systems Inc | Spaventa Andrew | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 915,000 | 915,000 | - | - | Restricted Stock Unit | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2023 | 14,583 | 4,075,789 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Spaventa Andrew | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 14,583 | 189,583 | - | - | Restricted Stock Units | |
| Singular Genomics Systems Inc | Spaventa Andrew | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2023 | 14,583 | 9,766 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Spaventa Andrew | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 14,583 | 24,349 | - | - | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 14,583 | 218,750 | - | - | Restricted Stock Units | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 14,583 | 24,349 | - | - | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Jun 2023 | 14,583 | 9,766 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Jun 2023 | 14,583 | 3,928,154 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 466,667 | 466,667 | - | - | Employee Stock Option (right to buy) | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 233,333 | 233,333 | - | - | Restricted Stock Unit | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 500,000 | 3,913,571 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 24 Mar 2022 | 173,144 | 0 | - | - | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 24 Mar 2022 | 9,766 | 9,766 | - | - | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 1,000,000 | 1,000,000 | - | - | Employee Stock Option (right to buy) | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 02 Dec 2021 | 715,884 | 173,144 | - | - | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | 01 Jun 2021 | 715,884 | 715,884 | - | - | Common Stock | ||
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | 01 Jun 2021 | 362,266 | 0 | - | - | Series Seed Preferred Stock | ||
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | 01 Jun 2021 | 201,155 | 0 | - | - | Series A Preferred Stock | ||
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | 01 Jun 2021 | 173,144 | 0 | - | - | Convertible Promissory Note | ||
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | 01 Jun 2021 | 173,144 | 889,028 | - | 17.6 | 3,047,334 | Common Stock | |
| Singular Genomics Systems Inc | Andrew Spaventa | Director, Chief Executive Officer | 01 Jun 2021 | 152,463 | 0 | - | - | Series B Preferred Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges